Phosphocyclocreatine is the dominant form of cyclocreatine in control and creatine transporter deficiency patient fibroblasts.

Autor:	Gorshkov, Kirill1 (AUTHOR) kirill.gorshkov@nih.gov, Wang, Amy Q.1 (AUTHOR) amy.wang@nih.gov, Sun, Wei1 (AUTHOR), Fisher, Ethan1 (AUTHOR), Frigeni, Marta2 (AUTHOR), Singleton, Marc1 (AUTHOR), Thorne, Natasha1 (AUTHOR), Class, Bradley1 (AUTHOR), Huang, Wenwei1 (AUTHOR), Longo, Nicola2,3 (AUTHOR), Do, Minh‐Ha T.4 (AUTHOR), Ottinger, Elizabeth A.1 (AUTHOR), Xu, Xin1 (AUTHOR), Zheng, Wei1 (AUTHOR) wzheng@mail.nih.gov
Zdroj:	Pharmacology Research & Perspectives. Dec2019, Vol. 7 Issue 6, p1-15. 15p.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu